Hamel Associates, Inc. Edwards Lifesciences Corp Transaction History

Hamel Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $241,040 - $301,185	-2,875 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$78.68 - $90.67 $45,241 - $52,135	-575 Reduced 16.67%	2,875 $240,000
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $132,342 - $176,985	2,300 Added 200.0%	3,450 $238,000
Q1 2019 May 01, 2019	BUY	$47.89 - $64.05 $55,073 - $73,657	1,150 New	1,150 $220,000
Q4 2018 Feb 08, 2019	SELL	$46.41 - $56.94 $53,371 - $65,481	-1,150 Closed	0 $0

Q3 2018 Oct 25, 2018	BUY	$45.7 - $58.03 $52,555 - $66,734	1,150 New	1,150 $200,000

1,384

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Hamel Associates, Inc. with notifications on news.